Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia-Reference-Cited by-同舟云学术

Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia

Published:2003-04 Issue:1-2 Volume:466 Page:155-161
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Amano Yuichiro,Nishimoto Tomoyuki,Tozawa Ryu-ichi,Ishikawa Eiichiro,Imura Yoshimi,Sugiyama Yasuo

Publisher

Elsevier BV

Subject

Pharmacology

Reference32 articles.

1. Cardiovascular complications of homozygous familial hypercholesterolemia;Allen;Br. Heart J.,1980

2. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase;Amin;J. Pharmacol. Exp. Ther.,1997

3. Antiatherosclerotic effects of YM548 in Watanabe heritable hyperlipidemic rabbits;Arai;Jpn. Pharmacol. Ther.,1998

4. Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo;Baxter;J. Biol. Chem.,1992

5. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors;Bisgaier;J. Lipid Res.,1997

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation;Biomolecules;2021-09-30

2. Repositioning of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice;Current Medicinal Chemistry;2018-07-04

3. Farnesoid X receptor antagonist exacerbates dyslipidemia in mice;Pharmacological Reports;2018-02

4. Anti-inflammatory and cytoprotective effects of a squalene synthase inhibitor, TAK-475 active metabolite-I, in immune cells simulating mevalonate kinase deficiency (MKD)-like condition;SpringerPlus;2016-08-30

5. Differential Regulation of Gene Expression by Cholesterol Biosynthesis Inhibitors That Reduce (Pravastatin) or Enhance (Squalestatin 1) Nonsterol Isoprenoid Levels in Primary Cultured Mouse and Rat Hepatocytes;Journal of Pharmacology and Experimental Therapeutics;2016-05-25